CD8A and glioma: In a mouse glioma model, metronomic 5-FU produced a selective reduction in blood MDSC levels, which is associated with an increase in CD8+-T cells and a reduction in Treg, which attenuated tumor immunosuppression and prolonged survival, whereas a higher dose did not [135].